ARTHUR S KIRSCH
CIK 1290976 · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.19M
Companies
7
Total Filings
48
Lifetime Open-Market Net
-$1.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EVMN | Director | 10,000 | $11.35 | $113.5K | $133.0K | 2 | 2026-07-08 |
| AVIR | Director | — | $4.75 | — | $0 | 2 | 2026-06-23 |
| LQDA | Director | 46,637 | $87.36 | $4.07M | -$1.60M | 10 | 2026-06-18 |
| Kadmon Holdings, Inc. (KDMN) Delisted | Director | 0 | $9.50 | $0 | $0 | 5 | 2021-11-09 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Director | 276,609 | — | — | $347.5K | 9 | 2017-12-12 |
| POZEN INC /NC (POZN) Delisted | Director | 58,612 | — | — | $66.5K | 11 | 2016-01-22 |
| IMMUNOMEDICS INC (IMMU) Delisted | Director | — | — | — | $0 | 2 | 2015-12-04 |
Recent Filings · Page 2 of 5
48 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-22 | LQDA | — | — | $0 | EDGAR |
| 2023-06-21 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2021-11-12 | LQDA | Buy (P) | +30,000 | $127.2K | EDGAR |
| 2021-11-09 | Kadmon Holdings, Inc. (KDMN) Delisted | Disp (D) | −30,000 | -$285.0K | EDGAR |
| 2021-09-01 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2021-05-17 | Kadmon Holdings, Inc. (KDMN) Delisted | Grant (A) | +30,000 | $108.5K | EDGAR |
| 2021-05-13 | Kadmon Holdings, Inc. (KDMN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-26 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2020-06-23 | — | Grant (A) | — | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.